JP2025511974A5 - - Google Patents
Info
- Publication number
- JP2025511974A5 JP2025511974A5 JP2024559703A JP2024559703A JP2025511974A5 JP 2025511974 A5 JP2025511974 A5 JP 2025511974A5 JP 2024559703 A JP2024559703 A JP 2024559703A JP 2024559703 A JP2024559703 A JP 2024559703A JP 2025511974 A5 JP2025511974 A5 JP 2025511974A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- group
- halogen
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22166685 | 2022-04-05 | ||
| EP22166685.2 | 2022-04-05 | ||
| PCT/EP2023/058978 WO2023194458A1 (en) | 2022-04-05 | 2023-04-05 | N-(3-(benzo[b]thiophene-2-carboxamido)-phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide derivatives and related compounds as lactate/atp production inhibitors for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511974A JP2025511974A (ja) | 2025-04-16 |
| JP2025511974A5 true JP2025511974A5 (https=) | 2026-04-13 |
Family
ID=81328159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559703A Pending JP2025511974A (ja) | 2022-04-05 | 2023-04-05 | がんの治療のためのラクテート／ＡＴＰ産生阻害剤としてのＮ－（３－（ベンゾ［ｂ］チオフェン－２－カルボキシアミド）－フェニル）－２，３－ジヒドロベンゾ［ｂ］［１，４］ジオキシン－６－カルボキシアミド誘導体及び関連化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260028334A1 (https=) |
| EP (1) | EP4504723A1 (https=) |
| JP (1) | JP2025511974A (https=) |
| KR (1) | KR20240172217A (https=) |
| CN (1) | CN118974040A (https=) |
| AU (1) | AU2023248671A1 (https=) |
| CA (1) | CA3246966A1 (https=) |
| IL (1) | IL316122A (https=) |
| MX (1) | MX2024012179A (https=) |
| WO (1) | WO2023194458A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202523302A (zh) | 2023-11-02 | 2025-06-16 | 美商阿克思生物科學有限公司 | 噻唑化合物及其使用方法 |
| WO2025165930A1 (en) * | 2024-01-31 | 2025-08-07 | Biogen Ma Inc. | Methods for treating spinal muscular atrophy |
| JP7818251B2 (ja) * | 2024-02-29 | 2026-02-20 | 株式会社Moresco | オートファジー機能活性化化合物 |
| CN118340765B (zh) * | 2024-04-30 | 2024-08-23 | 广州市朝利良生物科技有限公司 | 苯甲酰胺类化合物在制备促伤口愈合药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2547072T3 (es) * | 2009-07-21 | 2015-10-01 | The Board Of Trustees Of The Leland Stanford Junior University | Heteroaril benzamidas, composiciones y métodos de utilización |
| GB201317609D0 (en) | 2013-10-04 | 2013-11-20 | Cancer Rec Tech Ltd | Inhibitor compounds |
| GB201505658D0 (en) | 2015-04-01 | 2015-05-13 | Cancer Rec Tech Ltd | Inhibitor compounds |
| GB201617103D0 (en) * | 2016-10-07 | 2016-11-23 | Cancer Research Technology Limited | Compound |
-
2023
- 2023-04-05 EP EP23718214.2A patent/EP4504723A1/en active Pending
- 2023-04-05 JP JP2024559703A patent/JP2025511974A/ja active Pending
- 2023-04-05 AU AU2023248671A patent/AU2023248671A1/en active Pending
- 2023-04-05 CA CA3246966A patent/CA3246966A1/en active Pending
- 2023-04-05 CN CN202380032324.0A patent/CN118974040A/zh active Pending
- 2023-04-05 KR KR1020247036954A patent/KR20240172217A/ko active Pending
- 2023-04-05 WO PCT/EP2023/058978 patent/WO2023194458A1/en not_active Ceased
- 2023-04-05 US US18/854,499 patent/US20260028334A1/en active Pending
- 2023-04-05 IL IL316122A patent/IL316122A/en unknown
-
2024
- 2024-10-02 MX MX2024012179A patent/MX2024012179A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025511974A5 (https=) | ||
| US20200392083A1 (en) | Compound having pd-l1 inhibitory activity, preparation method therefor and use thereof | |
| CA3019450A1 (en) | Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application | |
| BRPI0814958B1 (pt) | Compostos de indol, e, composição | |
| JP2011510014A5 (https=) | ||
| JP2021102643A5 (https=) | ||
| CN114630830B (zh) | 新型化合物、包含其的药物组合物及其用途 | |
| JP2013538213A5 (https=) | ||
| JP2016525104A5 (https=) | ||
| WO2014186450A2 (en) | Highly potent inhibitors of porcupine | |
| CN116178456A (zh) | 用于克服铂耐受性的德克萨卟啉-pt(iv)缀合物及组合物 | |
| JP7416757B2 (ja) | 置換テトラヒドロシクロペンタ［ｃ］ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法 | |
| WO2021093172A1 (zh) | Hbv抑制剂及其用途 | |
| CN110891942B (zh) | 噁二唑类衍生物、其制备方法及其在医药上的应用 | |
| WO2004009556A9 (ja) | ４−置換アリール−５−ヒドロキシイソキノリノン誘導体 | |
| JP2017137323A (ja) | 新規抗がん剤 | |
| TWI638825B (zh) | 抑制癌症及病毒之化合物 | |
| CN115003650A (zh) | 二取代金刚烷基衍生物、其药学上可接受的盐及包含其作为有效成分的用于抑制癌生长的药物组合物 | |
| TWI827576B (zh) | 吲哚胺2,3-雙加氧酶抑制劑以及它們在醫學上的應用 | |
| JP2022502378A5 (https=) | ||
| WO2025116822A1 (en) | Near infrared fluorescence compounds and methods thereof | |
| CN108473449B (zh) | 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途 | |
| PT2692345T (pt) | Composição farmacêutica para prevenir ou tratar a degeneração macular | |
| JP3223193B2 (ja) | インドール誘導体およびそれらを有効成分とする抗癌剤耐性克服物質 | |
| CN115368263A (zh) | 一种肉桂酸酰胺衍生物的合成及其制药应用 |